Medicine and Dentistry
Surgery
100%
Liver Cirrhosis
78%
Stomach Carcinoma
71%
Narrow Band Imaging
71%
Colon Polyp
71%
Endoscopic Submucosal Dissection
71%
1 (2,4 Dichlorophenyl) 5 (4 Iodophenyl) 4 Methyl N (1 Piperidyl) 1h Pyrazole 3 Carboxamide
71%
Randomized Controlled Trial
71%
Liver Fibrosis
71%
In Vitro
71%
Systematic Review
71%
Pancreas Cancer
71%
Differential Diagnosis
71%
Meta-Analysis
71%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
71%
Cannabinoid 1 Receptor
71%
Chromoendoscopy
71%
Cannabinoid 1 Receptor Antagonist
71%
Colonoscopy
71%
Stomach Cancer
71%
Protein Kinase C
71%
Hyperlipidemia
71%
Cholestin
71%
Retrospective Cohort Study
71%
Polyp
62%
Immune System
47%
Hazard Ratio
38%
Diagnostic Accuracy
26%
Preoperative Period
23%
Subgroup Analysis
23%
Infectious Complication
23%
Malignant Neoplasm
21%
Lovastatin
19%
Endoscopic Mucosal Resection
14%
Systemic Disease
14%
Cancer
14%
Endoscopy
14%
Venous Ulcer
14%
Fibrosis
14%
Matrix-Assisted Laser Desorption-Ionization
13%
Biological Marker
13%
Immunohistochemistry
12%
Proportional Hazards Model
12%
Distant Metastasis
11%
Neoplasm
11%
Histopathology
8%
Sensitivity and Specificity
8%
Colorectal Cancer
8%
Colorectal Polyp
8%
Diagnosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Fibrosis
71%
Matrix-Assisted Laser Desorption/Ionization
71%
AM251
71%
Cannabinoid 1 Receptor Antagonist
71%
Cannabinoid 1 Receptor
71%
Indomethacin-Induced Gastric Ulcer
71%
Pancreas Cancer
71%
Stomach Carcinoma
71%
Randomized Controlled Trial
71%
Acute Hepatitis B
71%
Indometacin
71%
Antivirus Agent
71%
Protein Kinase C
71%
Liver Failure
71%
Itraconazole
71%
Antiinflammatory Activity
30%
Vaccination Policy
30%
Infectious Complication
23%
Biological Marker
13%
Distant Metastasis
11%
Onychomycosis
11%
Neoplasm
11%
Chondrus
10%
Chronic Hepatitis B
10%
Antiulcer Agent
10%
Hesperidin
10%
High Performance Liquid Chromatography
10%
Ulcer
10%
Paw Edema
10%
Glycyrrhizin
10%
Hepatitis B
10%
Wistar Rat
10%
Hepatitis B Virus
10%
Stomach Ulcer
10%
Hepatitis B Antibody
10%
Hepatitis B Vaccine
10%
Thioacetamide
6%
Liver Cirrhosis
6%
Malignant Neoplasm
6%
Eosin
6%
Haematoxylin
6%
Hepatic Coma
6%
Overall Survival
5%
Nursing and Health Professions
Confidence Interval
77%
Liver Cirrhosis
71%
Pancreas Cancer
71%
Cohort Analysis
71%
Hyperlipidemia
71%
Surgery
71%
Systematic Review
71%
Meta Analysis
71%
Cholestin
71%
Hazard Ratio
38%
Hospitalization
23%
Infectious Complication
23%
Preoperative Period
23%
Mevinolin
19%
Propensity Score
6%
Hepatic Coma
6%
Proportional Hazards Model
6%
Ascites
6%
Fatty Liver
6%
Independent Practice Association
6%
Compliance
6%
Jaundice
6%
